Fourteen states are reporting “high” respiratory virus activity: Arizona, Texas, Oklahoma, Nebraska, Minnesota, Wisconsin, Kentucky, Georgia, Florida, Pennsylvania, Maryland, New Jersey, Delaware and Connecticut.
Two are reporting “very high” levels: Hawaii and New Hampshire.
Here are four more updates:
- Nationally, emergency department visits for influenza and RSV remain high, while COVID-19 ED visits have increased compared to the fall. Flu and RSV test positivity are also elevated, with influenza positivity climbing to 18.8% and COVID-19 positivity steady at 6.6%. RSV test positivity has decreased to 8.9%.
- COVID-19 and influenza A levels in wastewater are high, indicating widespread viral activity. Meanwhile, RSV levels in wastewater remain at a moderate level, signaling a stabilization in many areas, according to the CDC.
- The agency forecasts that influenza-related ED visits will remain at a high to very high level in the coming weeks, while COVID-19 and RSV activity are expected to decrease slightly, though overall respiratory illness activity will remain elevated.
- Vaccination coverage remains a concern, with COVID-19 and influenza vaccine rates still relatively low among U.S. adults and children, particularly for RSV vaccines, which have seen lower uptake.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.